Skip to content
Research Article Open access CC BY 4.0

Understanding Host-Pathogen Interaction in the Cornea: Inflammatory Response and Cure

Suman Kumar, Vimal Singh Munda, Neha Sharad, Rajan Kumar, Maneesh Kumar, Ratnesh Kumar, Mithilesh Kumar Jha, Shashank Nand Tiwari, Pratima Gupta

International Journal of TROPICAL DISEASE & Health · pp. 206–216 · Published 2 Jun 2024

10.9734/ijtdh/2024/v45i61552

Abstract

Microbial keratitis is a serious disease of the cornea that poses a major risk to the health and vision of people all over the world. It is caused by various microbial invaders, including bacteria, fungi and viruses, making it difficult to diagnose and treat. Combating microbial keratitis requires understanding the intricate web of immune responses and pathogenic pathways that cause the infection. To develop innovative strategies to treat the disease and improve patient survival, we need to understand how the immune system works, how hosts and infections interact and how complicated the pathophysiology is. Looking to the future, we are on the cusp of a transformative era in treating microbial keratitis. Innovations in therapeutic technology, such as targeted antimicrobial drugs, immunomodulatory therapies and precision medicine techniques, are set to revolutionise the field. These advancements will enable customised treatments for specific microbiological causes and patient characteristics. Integrating molecular biology, imaging and artificial intelligence into novel diagnostic techniques will enhance early diagnosis and personalised treatment programmes, leading to better clinical outcomes and reduced ocular morbidity. Collaboration between clinicians, researchers, and industry representatives is critical to accelerating the translation of scientific knowledge into clinical practice. Improving patient care, increasing treatment efficacy and saving eyesight are the goals for the future of microbial keratitis treatment.

Microbial keratitis bacteria keratitis fungi keratitis inflammation corneal infection cytokines

References (32)

  1. 1 Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance [DOI]
  2. 2 Infectious keratitis: A review [DOI]
  3. 3 Bacterial profile of ocular infections: a systematic review [DOI]
  4. 4 Pathogenesis of microbial keratitis [DOI]
  5. 5 Mycotic Keratitis—A Global Threat from the Filamentous Fungi [DOI]
  6. 6 Nonencapsulated Streptococcus pneumoniae: Emergence and Pathogenesis [DOI]
  7. 7 Regenerative therapy for the Cornea [DOI]
  8. 8 Fungal keratitis: Pathogenesis, diagnosis and prevention [DOI]
  9. 9 Acanthamoeba Keratitis, Pathology, Diagnosis and Treatment [DOI]
  10. 10 Epidemiology, risk factors, and clinical outcomes in severe microbial keratitis in South India [DOI]
  11. 11 Distribution, Prevalence, and Causative Agents of Fungal Keratitis: A Systematic Review and Meta-Analysis (1990 to 2020) [DOI]
  12. 12 Staphylococcus aureus and Pseudomonas aeruginosa infectious keratitis: key bacterial mechanisms that mediate pathogenesis and emerging therapeutics [DOI]
  13. 13 Herpes simplex virus, varicella-zoster virus and cytomegalovirus keratitis: Facts for the clinician [DOI]
  14. 14 Risk Factors for Treatment Outcome in Fungal Keratitis [DOI]
  15. 15 Clinical Characteristics and Outcome of Candida Keratitis [DOI]
  16. 16 Risk factors for perforation in microbial corneal ulcers in north India [DOI]
  17. 17 Invisible shield: Review of the corneal epithelium as a barrier to UV radiation, pathogens, and other environmental stimuli [DOI]
  18. 18 Nocardia Keratitis: Clinical Course and Effect of Corticosteroids [DOI]
  19. 19 Epidemiology and the Estimated Burden of Microbial Keratitis on the Health Care System in Taiwan: A 14-Year Population-Based Study [DOI]
  20. 20 Ocular bacterial infections: Pathogenesis and diagnosis [DOI]
  21. 21 Understanding clinical and immunological features associated with Pseudomonas and Staphylococcus keratitis [DOI]
  22. 22 Epidemiological and microbiological profiles of microbial keratitis in a tertiary eye center in Eastern India (Bihar) [DOI]
  23. 23 Antimicrobial resistance in topical treatments for microbial keratitis: protocol for a systematic review and meta-analysis [DOI]
  24. 24 Public Awareness of Rheumatoid Arthritis and Ankylosing Spondylitis in Lebanon [DOI]
  25. 25 A 3½-Year Study of Bacterial Keratitis From Odisha, India [DOI]
  26. 26 Case Report: Alternaria alternata keratitis [DOI]
  27. 27 Emerging drugs for the treatment of herpetic keratitis [DOI]
  28. 28 Curvularia lunata causing orbital cellulitis in a diabetic patient: An old fungus in a new territory [DOI]
  29. 29 Evaluation of Serratia marcescens Adherence to Contact Lens Materials [DOI]
  30. 30 Infectious Keratitis: An Immediate Cause of Concern [DOI]
  31. 31 Microbial keratitis: Causative organisms, susceptibilities and trends at a tertiary eye hospital in South Africa [DOI]
  32. 32 Targeting posterior eye infections with colloidal carriers: The case of Ganciclovir [DOI]

Cited by 2

Implementing microbiome analysis in clinical practice: overcoming challenges

Maneesh Kumar, Suman Kumar, Ratnesh Kumar · Elsevier eBooks · 2026

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

50

Page views

0

PDF downloads

3

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.